Figure 1.
Incidence-prevalence-mortality model.
Illustrates the generic relationship between epidemiological parameters used by DisMod-MR to model epidemiological data.
Figure 2.
Summary of the raw data on prevalence (P), incidence (I), duration (D) and excess mortality (EM) of MDD.
Summarises the available epidemiological data used as inputs in the DisMod-MR modelling of MDD.
Table 1.
Study-level covariates used in the statistical modelling of MDD.
Figure 3.
Country- and study-level covariate adjustments for MDD.
Illustrates the effect of the covariates used in the DisMod-MR modelling of prevalence data.
Figure 4.
Prevalence of MDD before and after covariate adjustments for females from North Africa/Middle East, 2010.
Compares the raw prevalence estimates to the final pooled prevalence output generated by DisMod-MR for females from North Africa/Middle East, for 2010.
Figure 5.
Prevalence, incidence, duration and excess mortality of MDD in females from North America, High income, 2010.
Compares the raw prevalence, incidence, duration and excess mortality estimates to the final pooled prevalence, incidence, duration and excess mortality output generated by DisMod-MR for females from North America, High income, for 2010.
Figure 6.
Regional point prevalence of MDD by age and sex, 2010.
Presents the prevalence of MDD (as derived by DisMod-MR) by region, age and sex for 2010.
Figure 7.
The overall point prevalence of MDD and 95% uncertainty by region and age, 2010.
Presents the prevalence of MDD (as derived by DisMod-MR) by region and age for 2010.
Figure 8.
The number of point prevalent cases (in millions) of MDD by region, age and sex, 2010.
Presents the prevalent cases of MDD (as derived by DisMod-MR) by region, age and sex for 2010.